News

On September 10, 2020 the 22nd Annual Chip for Charity Golf Outing will be held at Kettle Hills Golf Course, in Richfield, Wisconsin.  Last year’s event raised $123,000 pushing the cumulative total to 1.6 million dollars! Proceeds from the golf outing are used to help the SSADH Association in its…

The SSADH Conference that was planned for Boston this July has been moved to a virtual format. The event will take place as two half day online presentations on July 9 and 10. Every effort was made to accommodate time zones and though we had to collapse the original agenda…

We are pleased to announce that we have opened sites in Barcelona, Spain and Oslo and Gottingen, Germany for patients to participate in the SSADH Natural History Study. Patients willing to participate in the SSADH Natural History Study from Spain should get in touch with Dr. Natalia Juliá (Neurologist) who…

We want to thank all those who participated in the 21st Annual Chip for Charity golf outing. Those of you who were able to join us know that we didn’t have our usual great weather, and even though it was misty, foggy and rather chilly, it didn’t keep anyone away.

Gamma-Hydroxybutyrate Content in Dried Bloodspots Facilitates Newborn Detection of Succinic Semialdehyde Dehydrogenase Deficiency. Further, development of a first-tier screening method for SSADHD employing metabolites currently measured (amino acids, acylcarnitines, creatine, guanidino species) is under study. Madalyn Brown, PhDUniversity of Washington State

Washington, DC, July 19, 2019—The National Organization for Rare Disorders (NORD)®, the leading independent nonprofit organization representing the over 25 million Americans with rare diseases, announces the appointment of four new members to its Board of Directors, effective immediately. Joining the Board of Directors are Kay Holcombe, Neil Horikoshi, Phillip…